Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Butterfly Network is a digital health company that has revolutionized medical imaging with the development of the Butterfly iQ, the world's first handheld, single-probe, whole-body ultrasound system. Utilizing proprietary "Ultrasound-on-Chip" technology, the company replaces traditional piezoelectric crystals with a single silicon chip, significantly reducing the cost and size of ultrasound devices. The system connects to mobile devices and leverages artificial intelligence to assist clinicians in capturing and interpreting images at the point of care. Butterfly Network became a publicly traded company in February 2021 following a business combination with the special purpose acquisition company (SPAC) Longview Acquisition Corp. The company's mission is to democratize medical imaging and make it accessible to healthcare providers globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Longview Acquisition.